Large Cell Lung Carcinoma clinical trials at UC Davis

2 research studies open to eligible people

Showing trials for

  • A Study of the Experimental Medicine Rucaparib for Recurrent Non-small Cell Lung Cancer

    open to all eligible people

    This phase II Lung-MAP trial studies how well rucaparib works in treating patients with genomic loss of heterozygosity (LOH) high and/or deleterious BRCA1/2 mutation stage IV non-small cell lung cancer or that has come back. Rucaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

    Sacramento, California and other locations

  • Genetic Testing in Patients with Non-Small Cell Lung Cancer Before or After Surgery

    “Studying the genes in a patient's tumor cells may help determine the best treatment for patients with certain genetic changes.”

    open to eligible people ages 18 years and up

    This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

    Sacramento, California and other locations

Our lead scientists for Large Cell Lung Carcinoma research studies include .

Last updated: